Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claudio Mussolino
325. Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements
Journal of Clinical Medicine
Related publications
X-Linked Lymphoproliferative Disease (XLP)
223. Lentiviral Vector Mediated Gene Therapy for X-Linked Lymphoproliferative Disease Restores Humoral and Cellular Functions
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Gene Therapy for X-Linked Chronic Granulomatous Disease (Net4CGD)
Human gene therapy. Clinical development
Genetics
A Rapid Flow Cytometric Screening Test for X-Linked Lymphoproliferative Disease Due to XIAP Deficiency
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Phenotypic Differences Between Mice Deficient in XIAP and SAP, Two Factors Targeted in X-Linked Lymphoproliferative Syndrome (XLP)
Cellular Immunology
Immunology
288. Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatous Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Targeted Disruption of Dkc1, the Gene Mutated in X-Linked Dyskeratosis Congenita, Causes Embryonic Lethality in Mice
Oncogene
Cancer Research
Genetics
Molecular Biology
